| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Salarius Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary | 1 | Reuters | ||
| Mo | Salarius Pharmaceuticals, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 22.04. | Salarius Pharmaceuticals, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 25.03. | Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket | 3 | Benzinga.com | ||
| 25.03. | Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday | 9 | Benzinga.com | ||
| 22.03. | Salarius Pharmaceuticals GAAP EPS of -$3.84 | 1 | Seeking Alpha | ||
| 22.03. | Salarius Pharmaceuticals, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 22.03. | Salarius Pharmaceuticals, Inc.: Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | 206 | GlobeNewswire (Europe) | Patient Enrollment Resumed in the Investigator-initiated Phase 1/2 Clinical Trial of Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Company Implemented Significant Expense-reduction... ► Artikel lesen | |
| 06.03. | Salarius Pharmaceuticals, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 22.02. | Salarius Pharmaceuticals Implements Cost-savings Measures | - | RTTNews | ||
| 03.01. | Salarius Pharmaceuticals, Inc.: Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals' Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment | 211 | GlobeNewswire (Europe) | HOUSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) announces that the hematologic cancer Phase 1/2 clinical trial being conducted at the University of Texas MD... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 7.154 |
| EVOTEC | 5.700 |
| TUI | 5.252 |
| PLUG POWER | 3.741 |
| NEL | 3.395 |
| AMC ENTERTAINMENT | 3.382 |
| BAYER | 2.630 |
| SIEMENS ENERGY | 2.459 |
| RHEINMETALL | 2.281 |
| NVIDIA | 2.268 |
| COMMERZBANK | 2.055 |
| AIXTRON SE | 1.808 |
| DEUTSCHE BANK | 1.779 |
| ALLIANZ | 1.702 |
| RWE | 1.641 |
| MERCEDES-BENZ | 1.586 |
| THYSSENKRUPP | 1.567 |
| BYD | 1.509 |
| THYSSENKRUPP NUCERA | 1.485 |
| SUPER MICRO COMPUTER | 1.433 |
| RENK GROUP | 1.413 |
| VOLKSWAGEN | 1.324 |
| NORDEX | 1.203 |
| ALIBABA | 1.173 |
| DEUTSCHE TELEKOM | 1.140 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
